FDA opens applications for pilot program to shorten drug approval times
The Food and Drug Administration announced Tuesday it is accepting applications for a new pilot program designed to speed up human testing for drugs.
Pilot program details announced
The agency stated the initiative aims to reduce the time required for drugmakers to begin testing products in humans. This effort is part of Operation TrialBlazer, a Department of Health and Human Services initiative first announced in June.
Goal to compete globally
The department wrote that the U.S. pathway often takes years while other countries measure theirs in months. The roadmap pledged to help the United States compete with rapidly accelerating biotechnology industries in nations like China and Australia.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.